Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer. [electronic resource]
Producer: 20210524Description: e145-e153 p. digitalISSN:- 1433-2981
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.